brusatol has been researched along with Hematologic Malignancies in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, Y; El-Deiry, WS; Hwang, N; Jha, HC; Lang, F; Pei, Y; Robertson, ES; Singh, RK; Wong, JH; Zhou, L | 1 |
1 other study(ies) available for brusatol and Hematologic Malignancies
| Article | Year |
|---|---|
Quassinoid analogs with enhanced efficacy for treatment of hematologic malignancies target the PI3Kγ isoform.
Topics: Animals; Class Ib Phosphatidylinositol 3-Kinase; Hematologic Neoplasms; Heterografts; Isoenzymes; Male; Mice; Mice, Inbred NOD; Quassins; Transplantation, Heterologous | 2020 |